Accentia Biopharmaceuticals Inc

CIK 1310094 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Accentia Biopharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Jan 15, 2016REVOKED9999999997-16-016326
Aug 10, 2015SC 13G/A0001457716-15-000025
Feb 9, 2015SC 13G0001193125-15-039232
Nov 12, 201340001214659-13-006340
Aug 15, 2013NT 10-Q0001214659-13-004708
Jul 15, 20138-K0001214659-13-003905
May 15, 2013NT 10-Q0001214659-13-002772
Mar 7, 20138-K0001214659-13-001282
Feb 22, 201340001214659-13-001013
Feb 22, 2013RW0001214659-13-000988
Feb 22, 20138-K0001214659-13-000986
Feb 14, 201310-Q0001214659-13-000877
Dec 26, 201210-K0001193125-12-514944
Nov 23, 20128-K0001193125-12-479724
Oct 26, 201240001181431-12-055667
Oct 15, 20128-K0001193125-12-423516
Sep 14, 201240001181431-12-050576
Sep 14, 201240001181431-12-050574
Sep 14, 201240001181431-12-050569
Sep 14, 201240001181431-12-050571
Aug 31, 201240001181431-12-048239
Aug 14, 20128-K0001193125-12-354215
Aug 14, 2012424B30001193125-12-354403
Aug 14, 201210-Q0001193125-12-354294
Aug 14, 2012424B30001193125-12-354392